Business growth
Aerie Pharmaceuticals has received FDA approval for the production and commercialization in the USA of 0.02% Rhopressa glaucoma solution. Deliveries to America will begin in Q4 2020.
Source: investors.aeriepharma.com
- BlackTerminal.com 2016 - 2026.